The costs of treating acute heart failure: an economic analysis of the SURVIVE trial.

Autor: de Lissovoy G; United BioSource Corporation, Center for Health Economics, Epidemiology and Science Policy, Bethesda, MD 20814, USA. greg.delissovoy@unitedbiosource.com, Fraeman K, Salon J, Chay Woodward T, Sterz R

Publikováno v: Journal of medical economics [J Med Econ] 2008; Vol. 11 (3), pp. 415-29.

eComment. Levosimendan in adult patients undergoing cardiac surgery.

Autor: Hajj-Chahine, Jamil

Publikováno v: Interactive Cardiovascular & Thoracic Surgery; Oct2013, Vol. 17 Issue 4, p715-715, 1p